Form 13G MacroGenics For: 5 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MacroGenics Inc (MGNX)
Track the MacroGenics Inc share price today and view real-time MGNX share price data, including charts, technicals, and key financials. View the MGNX premarket stock price ahead of the market session or assess the after hours quote. Explore MGNX stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the MacroGenics Inc Stock Price Today?
The MacroGenics Inc stock price today is 3.88.
What Is the Stock Symbol for MacroGenics Inc?
The stock symbol for MacroGenics Inc is ""MGNX.""
What Stock Exchange Does MacroGenics Inc Trade On?
MacroGenics Inc is listed and trades on the NASDAQ stock exchange.
Is MacroGenics Inc a Good Stock to Buy?
Determining whether MacroGenics Inc or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MGNX quote. (ISIN: US5560991094)
What Is the MacroGenics Inc Stock Price Today?
The MacroGenics Inc stock price today is 3.88.
What Is the Stock Symbol for MacroGenics Inc?
The stock symbol for MacroGenics Inc is ""MGNX.""
What Stock Exchange Does MacroGenics Inc Trade On?
MacroGenics Inc is listed and trades on the NASDAQ stock exchange.
Is MacroGenics Inc a Good Stock to Buy?
Determining whether MacroGenics Inc or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MGNX quote. (ISIN: US5560991094)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.84
4.06
52 wk Range
1.19
4.64
MGNX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.844.06
52 wk Range
1.194.64
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MGNX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
6.75
Upside
+73.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- Form 13G MACROGENICS For: 15 May
- Investing.com
- Form 13G MacroGenics For: 14 May
- Investing.com
- Form 13G MacroGenics For: 5 June
- Investing.com
- Form 13G MACROGENICS For: 15 May
- Investing.com
- Form 13G MacroGenics For: 14 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
4 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.75
(+73.97% Upside)
MacroGenics Inc SWOT Analysis
Pipeline Progress | Explore MacroGenics' evolving pipeline, featuring promising candidates like lorigerlimab and MGC026, as the company pivots from discontinued programs to new opportunities |
Financial Fortification | Delve into MacroGenics' strategic moves, including a $70M royalty agreement, extending cash runway to 2027 and bolstering its position for future growth |
Catalysts on Horizon | Uncover critical upcoming events for MacroGenics, including Phase 2 data readouts and potential partnerships, that could significantly impact company valuation |
Market Valuation | Analyst price targets range from $2 to $8 per share, reflecting diverse perspectives on MacroGenics' potential in a competitive biotech landscape |
MacroGenics Inc Earnings Call Summary for Q4/2024
- Q4 2024 EPS of -$0.07 beat expectations of -$0.40; revenue reached $49.4M, surpassing $29.19M forecast
- 2024 total revenue of $150M, up from $58.7M in 2023; net loss increased to $67M due to higher R&D expenses
- Cash balance of $201.7M extends runway into H2 2026; stock rose 4.29% in after-hours trading
- Clinical updates expected in H2 2025, including LORIKET trial data and MGC-26 dose expansion results
- CEO optimistic about 2025 pipeline advancement; CMO highlighted differentiated approach in checkpoint inhibitors
Last Updated: 21/03/2025, 08:30 am
Read Full TranscriptEarnings
Latest Release
13/05/2026
EPS / Forecast
-0.58 / -0.57
Revenue / Forecast
20.8M / 17.04M
Compare MGNX to Peers and Sector
Metrics to compare | MGNX | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipMGNXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.5x | −2.6x | −0.5x | |
PEG Ratio | 0.14 | 0.12 | 0.00 | |
Price/Book | 11.7x | 1.0x | 2.6x | |
Price / LTM Sales | 1.6x | 6.8x | 3.0x | |
Upside (Analyst Target) | 79.0% | 201.9% | 58.6% | |
Fair Value Upside | Unlock | 15.6% | 10.2% | Unlock |
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the MacroGenics Inc (MGNX) Stock Price Today?
The MacroGenics Inc stock price today is 3.88 USD.
What Stock Exchange Does MacroGenics Inc Trade On?
MacroGenics Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for MacroGenics Inc?
The stock symbol for MacroGenics Inc is "MGNX."
What Is the MacroGenics Inc Market Cap?
As of today, MacroGenics Inc market cap is 247.88M USD.
What Is MacroGenics Inc's Earnings Per Share (TTM)?
The MacroGenics Inc EPS (TTM) is -1.11.
When Is the Next MacroGenics Inc Earnings Date?
MacroGenics Inc will release its next earnings report on 11/08/2026.
From a Technical Analysis Perspective, Is MGNX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has MacroGenics Inc Stock Split?
MacroGenics Inc has split 0 times.
What is the current trading status of MacroGenics Inc (MGNX)?
As of 08/06/2026, MacroGenics Inc (MGNX) is trading at a price of 3.88 USD, with a previous close of 3.91 USD. The stock has fluctuated within a day range of 3.84 USD to 4.06 USD, while its 52-week range spans from 1.19 USD to 4.64 USD.
What Is MacroGenics Inc (MGNX) Price Target According to Analysts?
The average 12-month price target for MacroGenics Inc is 6.75 USD, with a high estimate of 9 USD and a low estimate of 4 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +73.97% Upside potential.
What Is the MGNX Premarket Price?
MGNX's last pre-market stock price is 3.89 USD. The pre-market share volume is 10.00, and the stock has decreased by -0.02, or -0.51%.
What Is the MGNX After Hours Price?
MGNX's last after hours stock price is 3.89 USD, the stock has decreased by 0.01, or 0.26%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.